Odds and associated factors for thrombosis development among Lebanese COVID-19 patients: a case-control retrospective study.

Mahmoud YounessSara MansourFouad SakrSamer OlabiSarah AtwiIman Younes MartinezSami El KhatibSouheil HallitPascale SalamehDiana MalaebHassan Hosseini

Published in: Journal of pharmaceutical policy and practice (2024)

Patients with COVID-19 and thromboembolism were at higher risk of mortality as compared to patients with COVID-19 but without thromboembolism. The use of anticoagulants significantly reduced the risk for thromboembolism.

Keyphrases

case control
sars cov
pulmonary embolism
cardiovascular events
cardiovascular disease
type diabetes
coronary artery disease
breast cancer risk